Chrono-oncology: Earlier-day immunochemotherapy delivery may be associated with improved outcomes in advanced NSCLC
A randomised phase III trial published in Nature Medicine has reported an association between the…
Browsing: Featured
Adjuvant aumolertinib significantly improves disease-free survival after resection of EGFR-mutant NSCLC
New data from the phase III ARTS trial published in The Lancet Oncology confirm that…
GLP-1 receptor agonists plus progestins and endometrial cancer risk in non-malignant uterine diseases
Endometrial cancer incidence continues to rise in many countries, particularly among women with metabolic dysfunction,…
App-based biometric coaching associated with improved clinician well-being and reduced burnout
Burnout among health care professionals has become a persistent and pressing issue, especially in high-stress…
New tool exposes scale of fake research flooding cancer science
A new machine learning tool has identified more than 250,000 cancer research papers that may…
Opportunistic salpingectomy as a preventive strategy for tubo-ovarian cancer
A new expert consensus published in JAMA supports the use of opportunistic salpingectomy as a…
Triple-targeted therapy shows unprecedented efficacy in early pancreatic cancer models
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest common cancers, with historically limited therapeutic…
AI-supported mammography screening results in fewer aggressive and advanced breast cancers
Artificial intelligence (AI)-supported mammography identifies more cancers during screening. It reduces the rate of breast…
Growing numbers of people living with metastatic breast cancer: a population-based study from Australia
Advances in breast cancer treatment over recent decades have transformed outcomes for many patients. Earlier…
Study identifies tumour progression pattern as predictor of survival after first-line NSCLC therapy
New Australian research published in Cancer Letters suggests that how advanced non-small cell lung cancer…